Completed PHASE1 INTERVENTIONAL 5-arm NCT01267903

A Clinical Trial for Inactivated Vaccine(Vero Cell) Against EV71 in Chinese Healthy Young Adults and Children

A Phase Ia Clinical Trial for Inactivated Vaccine(Vero Cell) Against EV71 in Chinese Healthy Young Adults and Children

Sponsor: Bejing Vigoo Biological Co., LTD

Interventions vaccine against EV71 of 160U/0.5ml vaccine against EV71 of 320U/0.5ml vaccine against EV71 of 640U/0.5ml

Updated 5 times since 2017 Last updated: Jun 9, 2011 Started: Jan 31, 2011 Primary completion: May 31, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Hand, Foot and Mouth Disease, this trial is completed. The trial is conducted by Bejing Vigoo Biological Co., LTD and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bejing Vigoo Biological Co., LTD
Jiangsu Province Centers for Disease Control and Prevention

Data source: Jiangsu Province Centers for Disease Control and Prevention

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.